Literature DB >> 24781960

Effects of telephone-based peer support in patients with type 2 diabetes mellitus receiving integrated care: a randomized clinical trial.

Juliana C N Chan1, Yi Sui2, Brian Oldenburg3, Yuying Zhang4, Harriet H Y Chung5, William Goggins6, Shimen Au7, Nicola Brown2, Risa Ozaki8, Rebecca Y M Wong4, Gary T C Ko4, Ed Fisher9.   

Abstract

IMPORTANCE: In type 2 diabetes mellitus (T2DM), team management using protocols with regular feedback improves clinical outcomes, although suboptimal self-management and psychological distress remain significant challenges.
OBJECTIVE: To investigate if frequent contacts through a telephone-based peer support program (Peer Support, Empowerment, and Remote Communication Linked by Information Technology [PEARL]) would improve cardiometabolic risk and health outcomes by enhancing psychological well-being and self-care in patients receiving integrated care implemented through a web-based multicomponent quality improvement program (JADE [Joint Asia Diabetes Evaluation]). DESIGN, SETTING, AND PARTICIPANTS: Between 2009 and 2010, 628 of 2766 Hong Kong Chinese patients with T2DM from 3 publicly funded hospital-based diabetes centers were randomized to the JADE + PEARL (n = 312) or JADE (n = 316) groups, with comprehensive assessment at 0 and 12 months.
INTERVENTIONS: Thirty-three motivated patients with well-controlled T2DM received 32 hours of training (four 8-hour workshops) to become peer supporters, with 10 patients assigned to each. Peer supporters called their peers at least 12 times, guided by a checklist. MAIN OUTCOMES AND MEASURES: Changes in hemoglobin A(1c) (HbA(1c)) level (primary), proportions of patients with attained treatment targets (HbA(1c) <7%; blood pressure <130/80 mm Hg; low-density lipoprotein cholesterol <2.6 mmol/L [to convert to milligrams per deciliter, divide by 0.0256]) (secondary), and other health outcomes at month 12.
RESULTS: Both groups had similar baseline characteristics (mean [SD] age, 54.7 [9.3] years; 57% men; disease duration, 9.4 [7.7] years; HbA(1c) level, 8.2% [1.6%]; systolic blood pressure, 136 [19] mm Hg; low-density lipoprotein cholesterol level, 2.89 [0.82] mmol/L; 17.4% cardiovascular-renal complications; and 34.9% insulin treated). After a mean (SD) follow-up period of 414 (55) days, 5 patients had died, 144 had at least 1 hospitalization, and 586 had repeated comprehensive assessments. On intention-to-treat analysis, both groups had similar reductions in HbA(1c) (JADE + PEARL, 0.30% [95% CI, 0.12%-0.47%], vs JADE, 0.29% [95% CI, 0.12%-0.47%] [P = .97]) and improvements in treatment targets and psychological-behavioral measures. In the JADE + PEARL group, 90% of patients maintained contacts with their peer supporters, with a median of 20 calls per patient. Most of the discussion items were related to self-management. CONCLUSIONS AND RELEVANCE: In patients with T2DM receiving integrated care, peer support did not improve cardiometabolic risks or psychological well-being. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00950716.

Entities:  

Mesh:

Year:  2014        PMID: 24781960     DOI: 10.1001/jamainternmed.2014.655

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN: 2168-6106            Impact factor:   21.873


  40 in total

1.  Contributions of Peer Support to Health, Health Care, and Prevention: Papers from Peers for Progress.

Authors:  Edwin B Fisher; Guadalupe X Ayala; Leticia Ibarra; Andrea L Cherrington; John P Elder; Tricia S Tang; Michele Heisler; Monika M Safford; David Simmons
Journal:  Ann Fam Med       Date:  2015-08       Impact factor: 5.166

2.  The Complexity of Complex Patients.

Authors:  Monika M Safford
Journal:  J Gen Intern Med       Date:  2015-12       Impact factor: 5.128

Review 3.  Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials.

Authors:  Labib Imran Faruque; Natasha Wiebe; Arash Ehteshami-Afshar; Yuanchen Liu; Neda Dianati-Maleki; Brenda R Hemmelgarn; Braden J Manns; Marcello Tonelli
Journal:  CMAJ       Date:  2016-10-31       Impact factor: 8.262

Review 4.  Social Support for Diabetes Self-Management via eHealth Interventions.

Authors:  Allison Vorderstrasse; Allison Lewinski; Gail D'Eramo Melkus; Constance Johnson
Journal:  Curr Diab Rep       Date:  2016-07       Impact factor: 4.810

5.  Mobile-Enhanced Peer Support for African Americans with Type 2 Diabetes: a Randomized Controlled Trial.

Authors:  Caroline Presley; April Agne; Tanya Shelton; Robert Oster; Andrea Cherrington
Journal:  J Gen Intern Med       Date:  2020-07-22       Impact factor: 5.128

Review 6.  Connected health: a review of the literature.

Authors:  Karen Colorafi
Journal:  Mhealth       Date:  2016-04-14

Review 7.  Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis.

Authors:  Lee Ling Lim; Eric S H Lau; Alice P S Kong; Melanie J Davies; Naomi S Levitt; Björn Eliasson; Carlos A Aguilar-Salinas; Guang Ning; Yutaka Seino; Wing Yee So; Margaret McGill; Graham D Ogle; Trevor J Orchard; Philip Clarke; Rury R Holman; Edward W Gregg; Juan José Gagliardino; Juliana C N Chan
Journal:  Diabetes Care       Date:  2018-06       Impact factor: 19.112

8.  Social Influences of Help-Seeking Behaviour Among Patients With Type 2 Diabetes Mellitus in Malaysia.

Authors:  Lee Lan Low; Seng Fah Tong; Wah Yun Low
Journal:  Asia Pac J Public Health       Date:  2015-07-28       Impact factor: 1.399

9.  Peer Support for Diabetes Management in Primary Care and Community Settings in Anhui Province, China.

Authors:  Xuefeng Zhong; Zhimin Wang; Edwin B Fisher; Chanuantong Tanasugarn
Journal:  Ann Fam Med       Date:  2015-08       Impact factor: 5.166

10.  Effects of Providing Peer Support on Diabetes Management in People With Type 2 Diabetes.

Authors:  Junmei Yin; Rebecca Wong; Shimen Au; Harriet Chung; Maggie Lau; Laihar Lin; Chiuchi Tsang; Kampiu Lau; Risa Ozaki; Wingyee So; Gary Ko; Andrea Luk; Roseanne Yeung; Juliana C N Chan
Journal:  Ann Fam Med       Date:  2015-08       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.